(Q49089264)

English

Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis.

scientific article published on 5 July 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21729978%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21729978%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

multiple sclerosis

0 references

clinically isolated syndrome

1 reference

based on heuristic

inferred from title

Nicola Filippini

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21729978%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Serena Ruggieri

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21729978%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Claudio Gasperini

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21729978%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Nicola De Stefano

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21729978%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

E Sbardella

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21729978%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

V Tomassini

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21729978%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

M L Stromillo

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21729978%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

M Battaglini

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21729978%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

L Ausili Cefaro

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21729978%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

E Raz

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21729978%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

M P Sormani

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21729978%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

P Pantano

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21729978%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

C Pozzilli

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21729978%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

5 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21729978%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21729978%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21729978%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21729978%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1432-1440

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21729978%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Baseline MRI predicts future attacks and disability in clinically isolated syndromes.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

MRI only conversion to multiple sclerosis following a clinically isolated syndrome.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Pathological abnormalities in the normal-appearing white matter in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Multiple sclerosis lesions: insights from imaging techniques

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Clinically isolated syndrome suggestive of multiple sclerosis: voxelwise regional investigation of white and gray matter

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Gray- and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Axonal loss in normal-appearing white matter in a patient with acute MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Regional grey matter atrophy in clinically isolated syndromes at presentation

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

MRI quantification of gray and white matter damage in patients with early-onset multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Imaging axonal damage of normal-appearing white matter in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Non-conventional MRI techniques for measuring neuroprotection, repair and plasticity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Gray matter pathology in (chronic) MS: modern views on an early observation

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Evidence of early cortical atrophy in MS: relevance to white matter changes and disability

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

On the evaluation of disability in multiple sclerosis. 1961.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Accurate, robust, and automated longitudinal and cross-sectional brain change analysis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Good results for early treatment of clinically isolated syndrome prior to multiple sclerosis with interferon beta-1b and glatiramer group

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

MR spectroscopy in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

MRI criteria for MS in patients with clinically isolated syndromes

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Enhanced brain extraction improves the accuracy of brain atrophy estimation

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

A three-year, multi-parametric MRI study in patients at presentation with CIS

1 reference

https://api.crossref.org/works/10.1177%2F1352458511414602

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49089264&oldid=1520162839"